| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.076 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |